Inicio › Sobrepeso › Carolina del Norte › Wilmington
Ensayos clínicos de Sobrepeso en Wilmington, NC
11 estudios para Sobrepeso buscan participantes en centros de Wilmington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ReclutandoFase 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
ReclutandoFase 2
- TMA Headlands, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
ReclutandoFase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
ReclutandoFase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ReclutandoFase 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutandoFase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ReclutandoFase 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
ReclutandoFase 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ReclutandoFase 3
- Accellacare Research of Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ReclutandoFase 3
- ACCOMPLISH-1 Research Site, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
ReclutandoFase 1
- Accellacare, Wilmington
Ensayos de Sobrepeso en otras ciudades
- San Antonio, TX34 estudios
- Houston, TX33 estudios
- Chicago, IL28 estudios
- Orlando, FL27 estudios
- Las Vegas, NV23 estudios
- Miami, FL23 estudios
- Atlanta, GA20 estudios
- Dallas, TX20 estudios
- New York City, NY19 estudios
- Jacksonville, FL19 estudios
- Washington, DC19 estudios
- Austin, TX18 estudios
Otros estudios en Wilmington
- Obesidad15 estudios
- Diabetes tipo 28 estudios
- Fallo cardíaco6 estudios
- Colitis ulcerativa4 estudios
- Presión arterial alta3 estudios
- Enfermedad cardiovascular3 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.